VRTX:NASDAQ
Vertex Pharmaceuticals Inc
$524.78
arrow_downward
-0.55%(-2.89) 1D
Sep 29, 10:05:48 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VRTX...
Open
$522.22
High
$529.46
Low
$522.22
Mkt. cap
133.11B
Avg. vol.
1.03M
Volume
28.45K
P/E ratio
30.56
52-wk high
$560.25
52-wk low
$385.86
EPS
$17.19
Beta
0.32
Shares outstanding
253.46M
No. of employees
6K
Open
$522.22
High
$529.46
Low
$522.22
Mkt. cap
133.11B
Avg. vol.
1.03M
Volume
28.45K
P/E ratio
30.56
52-wk high
$560.25
52-wk low
$385.86
EPS
$17.19
Beta
0.32
Shares outstanding
253.46M
No. of employees
6K
News stories
From web sources and news partners
Seeking Alpha
·
1 hour ago
Vertex Pharmaceuticals- Still Too Much Emphasis On CF Supremacy - I Foresee A Downgrade
Yahoo Finance
·
4 hours ago
2 Wall Street Analysts Think Vertex Pharmaceuticals Stock Can Soar Another 20% or More Over the Next 12 Months. Here's Why They're Right.
Insider Monkey
·
13 hours ago
Could Vertex Pharmaceuticals (VRTX)’s Kidney Breakthrough Unlock a New Opportunity for Maze Therapeutics (MAZE)?
GuruFocus
·
18 hours ago
VRTX Maintains Buy Rating by UBS -- Price Target Raised to $615
Profile
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
About Vertex Pharmaceuticals Inc
CEOReshma Kewalramani
Employees6.4K
Founded1989
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitevrtx.com